<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e405c-6be6-7581-9c39-f5f08b2a969f,g:b24e4bdc-e3e9-4da3-816a-10ae9fb538ac-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/CONDENSEDBALANCESHEETS" xlink:type="simple" xlink:href="intensity-20260630.xsd#CONDENSEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/CONDENSEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e405c-6ca4-772e-8ebe-d8f831eaecc3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e405c-6ca4-7917-9ae1-218e8c6c29f2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e405c-6ca4-772e-8ebe-d8f831eaecc3" xlink:to="loc_us-gaap_CommonStockValue_019e405c-6ca4-7917-9ae1-218e8c6c29f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e405c-6ca4-769e-a988-8ebcb293b5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e405c-6ca4-772e-8ebe-d8f831eaecc3" xlink:to="loc_us-gaap_PreferredStockValue_019e405c-6ca4-769e-a988-8ebcb293b5e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019e405c-6ca4-7365-8c9f-4065bdfb6e87" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e405c-6ca4-772e-8ebe-d8f831eaecc3" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019e405c-6ca4-7365-8c9f-4065bdfb6e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e405c-6ca4-77b5-ac3b-5c81988b8da2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e405c-6ca4-772e-8ebe-d8f831eaecc3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e405c-6ca4-77b5-ac3b-5c81988b8da2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e405c-6ca4-78a3-8ee2-f27a7bd4f547" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e405c-6ca4-7805-b805-596f49004d07" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e405c-6ca4-78a3-8ee2-f27a7bd4f547" xlink:to="loc_us-gaap_StockholdersEquity_019e405c-6ca4-7805-b805-596f49004d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e405c-6ca4-78d4-9428-2ccdeba5a84d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e405c-6ca4-78a3-8ee2-f27a7bd4f547" xlink:to="loc_us-gaap_Liabilities_019e405c-6ca4-78d4-9428-2ccdeba5a84d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019fd5ca-4d03-7b64-a4b2-e1fb20c73d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e405c-6ca4-78a3-8ee2-f27a7bd4f547" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019fd5ca-4d03-7b64-a4b2-e1fb20c73d1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e405c-6ca4-7b1b-b12a-d2314e43609f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e405c-6ca4-7628-a325-9a5db6a730cb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e405c-6ca4-7b1b-b12a-d2314e43609f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e405c-6ca4-7628-a325-9a5db6a730cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e405c-6ca4-7bc5-a69b-47f81046daf9" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e405c-6ca4-7b1b-b12a-d2314e43609f" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e405c-6ca4-7bc5-a69b-47f81046daf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e405c-6ca4-74c5-8029-b9d4ef1424d8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e405c-6ca4-731f-b87a-f1943551537c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e405c-6ca4-74c5-8029-b9d4ef1424d8" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019e405c-6ca4-731f-b87a-f1943551537c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e405c-6ca4-7833-a881-c803402a2d75" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e405c-6ca4-74c5-8029-b9d4ef1424d8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e405c-6ca4-7833-a881-c803402a2d75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e405c-6ca4-7d34-8ea3-a300be2565e5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e405c-6ca4-796a-8b00-a1a906654d96" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e405c-6ca4-7d34-8ea3-a300be2565e5" xlink:to="loc_us-gaap_AssetsCurrent_019e405c-6ca4-796a-8b00-a1a906654d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e405c-6ca4-7f87-8daf-de594b1e2b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e405c-6ca4-7d34-8ea3-a300be2565e5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e405c-6ca4-7f87-8daf-de594b1e2b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019e405c-6ca4-705e-961e-e476ae811893" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e405c-6ca4-7d34-8ea3-a300be2565e5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019e405c-6ca4-705e-961e-e476ae811893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e405c-6ca4-7275-a165-9fdfc7fe3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e405c-6ca4-777e-bb61-4c5737b5a990" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e405c-6ca4-7275-a165-9fdfc7fe3a0a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019e405c-6ca4-777e-bb61-4c5737b5a990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e405c-6ca4-7856-b33f-7b381587f187" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e405c-6ca4-7275-a165-9fdfc7fe3a0a" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e405c-6ca4-7856-b33f-7b381587f187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e405c-6ca4-73d5-846d-fc7597cf8bba" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e405c-6ca4-7275-a165-9fdfc7fe3a0a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e405c-6ca4-73d5-846d-fc7597cf8bba" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/CONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="intensity-20260630.xsd#CONDENSEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/CONDENSEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e405c-6ca4-7169-990f-fd93eec22da7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019e405c-6ca4-78b2-8f08-b6c994b3a10e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e405c-6ca4-7169-990f-fd93eec22da7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019e405c-6ca4-78b2-8f08-b6c994b3a10e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca4-7433-9507-5e73fd410f64" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e405c-6ca4-7169-990f-fd93eec22da7" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca4-7433-9507-5e73fd410f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019e405c-6ca4-78bd-b043-fc723af19127" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e405c-6ca4-7169-990f-fd93eec22da7" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019e405c-6ca4-78bd-b043-fc723af19127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e405c-6ca4-7d8d-a737-8abf2a64d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca4-7734-9761-5af3d7a12d85" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e405c-6ca4-7d8d-a737-8abf2a64d6b8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca4-7734-9761-5af3d7a12d85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca4-7086-8b3b-0f2bc48a5518" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e405c-6ca4-7d8d-a737-8abf2a64d6b8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca4-7086-8b3b-0f2bc48a5518" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca4-7fc6-9af7-ab21959bfbad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e405c-6ca4-7033-8849-f44a77dfefbb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca4-7fc6-9af7-ab21959bfbad" xlink:to="loc_us-gaap_OperatingExpenses_019e405c-6ca4-7033-8849-f44a77dfefbb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/CONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="intensity-20260630.xsd#CONDENSEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/CONDENSEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca4-71e2-bd77-78a6ab777449" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e405c-6ca4-71fb-8396-2f8ea2efc140" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca4-71e2-bd77-78a6ab777449" xlink:to="loc_us-gaap_NetIncomeLoss_019e405c-6ca4-71fb-8396-2f8ea2efc140" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e405c-6ca4-7602-9640-b91919a03b12" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca4-71e2-bd77-78a6ab777449" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019e405c-6ca4-7602-9640-b91919a03b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e405c-6ca5-782e-a616-a16bd482e670" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca4-71e2-bd77-78a6ab777449" xlink:to="loc_us-gaap_ShareBasedCompensation_019e405c-6ca5-782e-a616-a16bd482e670" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e405c-6ca5-7955-a907-3aab2d575030" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca4-71e2-bd77-78a6ab777449" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e405c-6ca5-7955-a907-3aab2d575030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019e405c-6ca5-781c-a191-8769914b6807" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca4-71e2-bd77-78a6ab777449" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_019e405c-6ca5-781c-a191-8769914b6807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e405c-6ca4-7300-af5d-7f32d0bd3c41" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019e405c-6ca4-723e-b285-6be99e2c8b63" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e405c-6ca4-7300-af5d-7f32d0bd3c41" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019e405c-6ca4-723e-b285-6be99e2c8b63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e405c-6ca4-715d-8a52-51067ecbd504" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e405c-6ca4-7300-af5d-7f32d0bd3c41" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e405c-6ca4-715d-8a52-51067ecbd504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_019eee5a-7a4a-731d-ac56-15b0480d04ee" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e405c-6ca4-7300-af5d-7f32d0bd3c41" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_019eee5a-7a4a-731d-ac56-15b0480d04ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e405c-6ca5-76d7-af00-11311f8ebb83" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca5-756c-b03a-431e290e102b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e405c-6ca5-76d7-af00-11311f8ebb83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e405c-6ca5-756c-b03a-431e290e102b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e405c-6ca5-7839-a524-f8edcf32bfd2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e405c-6ca5-76d7-af00-11311f8ebb83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e405c-6ca5-7839-a524-f8edcf32bfd2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/CashandCashEquivalentsDetails" xlink:type="simple" xlink:href="intensity-20260630.xsd#CashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/CashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e405c-6ca5-7b11-8c96-ee2ac1730180" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_019e405c-6ca5-7141-8c28-972fbe7e033e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e405c-6ca5-7b11-8c96-ee2ac1730180" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_019e405c-6ca5-7141-8c28-972fbe7e033e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_019e405c-6ca5-7330-8091-15890fbe3baf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Cash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019e405c-6ca5-7b11-8c96-ee2ac1730180" xlink:to="loc_us-gaap_Cash_019e405c-6ca5-7330-8091-15890fbe3baf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="intensity-20260630.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019e405c-6ca5-7ea9-bd97-ec3986fa642d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_PrepaidResearchAndDevelopmentCostCurrent_019e405c-6ca5-7d3c-998f-2d53b5e3c668" xlink:href="intensity-20260630.xsd#intensity_PrepaidResearchAndDevelopmentCostCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019e405c-6ca5-7ea9-bd97-ec3986fa642d" xlink:to="loc_intensity_PrepaidResearchAndDevelopmentCostCurrent_019e405c-6ca5-7d3c-998f-2d53b5e3c668" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_019e405c-6ca5-71ff-a549-9dd72be1c720" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019e405c-6ca5-7ea9-bd97-ec3986fa642d" xlink:to="loc_us-gaap_PrepaidInsurance_019e405c-6ca5-71ff-a549-9dd72be1c720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_019e405c-6ca5-7a7d-adb7-06dacd9ac948" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_019e405c-6ca5-7ea9-bd97-ec3986fa642d" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_019e405c-6ca5-7a7d-adb7-06dacd9ac948" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="intensity-20260630.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e405c-6ca5-79a0-8074-cf8126a4e01f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e405c-6ca5-701e-ba87-9ddf02d374e1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e405c-6ca5-79a0-8074-cf8126a4e01f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e405c-6ca5-701e-ba87-9ddf02d374e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e405c-6ca5-7c8a-9146-80861005b8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e405c-6ca5-79a0-8074-cf8126a4e01f" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e405c-6ca5-7c8a-9146-80861005b8ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_AccruedResearchAndDevelopmentCostCurrent_019e405c-6ca5-7f06-9245-8335e09526db" xlink:href="intensity-20260630.xsd#intensity_AccruedResearchAndDevelopmentCostCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e405c-6ca5-79a0-8074-cf8126a4e01f" xlink:to="loc_intensity_AccruedResearchAndDevelopmentCostCurrent_019e405c-6ca5-7f06-9245-8335e09526db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/LeasesScheduleofBalanceSheetClassificationDetails" xlink:type="simple" xlink:href="intensity-20260630.xsd#LeasesScheduleofBalanceSheetClassificationDetails"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/LeasesScheduleofBalanceSheetClassificationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019e405c-6ca5-70b7-940f-24262e37fc06" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e405c-6ca5-72fd-ad49-84a7a02e69b5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_019e405c-6ca5-70b7-940f-24262e37fc06" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e405c-6ca5-72fd-ad49-84a7a02e69b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e405c-6ca5-7247-b131-db02f980fbd2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_019e405c-6ca5-70b7-940f-24262e37fc06" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019e405c-6ca5-7247-b131-db02f980fbd2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/LeasesScheduleofMaturityDetails" xlink:type="simple" xlink:href="intensity-20260630.xsd#LeasesScheduleofMaturityDetails"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/LeasesScheduleofMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-725a-ad47-4b2ef11e0d44" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e405c-6ca5-77c1-8cde-66c2d010042d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-725a-ad47-4b2ef11e0d44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019e405c-6ca5-77c1-8cde-66c2d010042d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e405c-6ca5-72e9-ae25-ca96f36e3dab" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-725a-ad47-4b2ef11e0d44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019e405c-6ca5-72e9-ae25-ca96f36e3dab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e405c-6ca5-79df-b0f6-aca913f79451" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-725a-ad47-4b2ef11e0d44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019e405c-6ca5-79df-b0f6-aca913f79451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e405c-6ca5-7dab-8bbb-a8fd053e556f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-725a-ad47-4b2ef11e0d44" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019e405c-6ca5-7dab-8bbb-a8fd053e556f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/LeasesScheduleofMaturityDetails_1" xlink:type="simple" xlink:href="intensity-20260630.xsd#LeasesScheduleofMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/LeasesScheduleofMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-7747-acb8-5c0ec6be55c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e405c-6ca5-7e28-a860-0aface7f0298" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-7747-acb8-5c0ec6be55c5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019e405c-6ca5-7e28-a860-0aface7f0298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019e405c-6ca5-7e23-890e-460dd34ac68c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019e405c-6ca5-7747-acb8-5c0ec6be55c5" xlink:to="loc_us-gaap_OperatingLeaseLiability_019e405c-6ca5-7e23-890e-460dd34ac68c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://intensitytherapeutics.com/role/SegmentsDetails" xlink:type="simple" xlink:href="intensity-20260630.xsd#SegmentsDetails"/>
  <link:calculationLink xlink:role="http://intensitytherapeutics.com/role/SegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-705c-831e-7576478cf665" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingCosts_019e405c-6ca5-70c1-b2e3-49a278b04b92" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ManufacturingCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-705c-831e-7576478cf665" xlink:to="loc_us-gaap_ManufacturingCosts_019e405c-6ca5-70c1-b2e3-49a278b04b92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_ClinicalTrialExpenses_019e405c-6ca5-7dbf-92b5-1698c84d589d" xlink:href="intensity-20260630.xsd#intensity_ClinicalTrialExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-705c-831e-7576478cf665" xlink:to="loc_intensity_ClinicalTrialExpenses_019e405c-6ca5-7dbf-92b5-1698c84d589d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_SalariesAndBenefitsRelated_019e405c-6ca5-75cb-a1d5-c37000b5f900" xlink:href="intensity-20260630.xsd#intensity_SalariesAndBenefitsRelated"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-705c-831e-7576478cf665" xlink:to="loc_intensity_SalariesAndBenefitsRelated_019e405c-6ca5-75cb-a1d5-c37000b5f900" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_ConsultingAndOtherExpenses_019e405c-6ca5-7330-a58e-05a6184fe0f3" xlink:href="intensity-20260630.xsd#intensity_ConsultingAndOtherExpenses"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-705c-831e-7576478cf665" xlink:to="loc_intensity_ConsultingAndOtherExpenses_019e405c-6ca5-7330-a58e-05a6184fe0f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_ResearchAndDevelopmentExpenseSalariesAndBenefits_019e405c-6ca5-7017-abba-5042d78e84df" xlink:href="intensity-20260630.xsd#intensity_ResearchAndDevelopmentExpenseSalariesAndBenefits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-705c-831e-7576478cf665" xlink:to="loc_intensity_ResearchAndDevelopmentExpenseSalariesAndBenefits_019e405c-6ca5-7017-abba-5042d78e84df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e405c-6ca5-7687-bf30-db48775683c3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e405c-6ca5-7a55-8f69-bfc5e8a78708" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e405c-6ca5-7687-bf30-db48775683c3" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e405c-6ca5-7a55-8f69-bfc5e8a78708" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca5-718e-91d3-b04ec5e230e4" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e405c-6ca5-7687-bf30-db48775683c3" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca5-718e-91d3-b04ec5e230e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_019e405c-6ca5-728e-a80e-5a997f06ebbd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_019e405c-6ca5-728e-a80e-5a997f06ebbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_ConsultingExpenses_019e405c-6ca5-79c2-8a0e-934e7197bb5c" xlink:href="intensity-20260630.xsd#intensity_ConsultingExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_intensity_ConsultingExpenses_019e405c-6ca5-79c2-8a0e-934e7197bb5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_019e405c-6ca5-7600-b620-c922ac82a007" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LegalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_us-gaap_LegalFees_019e405c-6ca5-7600-b620-c922ac82a007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LaborAndRelatedExpense_019e405c-6ca5-74db-9b92-1c6e1eefc667" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LaborAndRelatedExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_us-gaap_LaborAndRelatedExpense_019e405c-6ca5-74db-9b92-1c6e1eefc667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralInsuranceExpense_019e405c-6ca5-77de-922d-52a233432add" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralInsuranceExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_us-gaap_GeneralInsuranceExpense_019e405c-6ca5-77de-922d-52a233432add" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_intensity_AuditFees_019e405c-6ca5-7ffd-91af-1816f505d9a0" xlink:href="intensity-20260630.xsd#intensity_AuditFees"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_intensity_AuditFees_019e405c-6ca5-7ffd-91af-1816f505d9a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e405c-6ca5-725c-8e9e-54d12afd7db8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-7c51-8e25-445305c3a9c2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e405c-6ca5-725c-8e9e-54d12afd7db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca5-771a-9863-639530882afb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-7e55-b288-0a5b7bf13c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca5-771a-9863-639530882afb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019e405c-6ca5-7e55-b288-0a5b7bf13c3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-709b-abff-3e8f899bb576" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e405c-6ca5-771a-9863-639530882afb" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019e405c-6ca5-709b-abff-3e8f899bb576" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
